Michael Silver

FDA Approves Treosulfan Combo Injection for HSCT Conditioning in AML/MDS

Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates

Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets

OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer

FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications

Extent of Prior Therapy Does Not Impact Radiotherapy Response in Myeloma